These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12746011)

  • 1. A process model of Depo-Provera use in Canadian women.
    Hampton M; McWatters B
    Health Care Women Int; 2003 Mar; 24(3):193-208. PubMed ID: 12746011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying barriers to emergency contraception use among young women from various sociocultural groups in British Columbia, Canada.
    Shoveller J; Chabot C; Soon JA; Levine M
    Perspect Sex Reprod Health; 2007 Mar; 39(1):13-20. PubMed ID: 17355377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Knowledge, attitudes and practices about contraception in an urban population].
    Chebaro R; El Tayyara L; Ghazzawi F; Abi Saleh B
    East Mediterr Health J; 2005 Jul; 11(4):573-85. PubMed ID: 16700371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depot medroxyprogesterone injectable contraception at the University of Uyo Teaching Hospital, Uyo.
    Abasiattai AM; Udoma EJ; Ukeme E
    Ann Afr Med; 2010; 9(2):81-5. PubMed ID: 20587929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and acceptability of depo-medroxyprogesterone acetate injection. As a method of contraception in Saudi Arabia.
    Sobande AA; Al-Bar HM; Archibong EI; Sadek AA
    Saudi Med J; 2000 Apr; 21(4):348-51. PubMed ID: 11533816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depo-Provera -- proving its innocence.
    Choudhury IR
    Indian Med Trib; 1994 Jul; 2(11):5. PubMed ID: 12179187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depo-provera: clinical evaluation.
    Mukherjea M
    Contracept Deliv Syst; 1981 Jul; 2(3):259-69. PubMed ID: 12278913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adolescent knowledge and use of injectable contraceptives in developing countries.
    Singh S
    J Adolesc Health; 1995 May; 16(5):396-404. PubMed ID: 7662691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Concept of compliance: analysis and example related to oral contraception].
    Rioux H; Sylvain H
    Rech Soins Infirm; 2004 Jun; (77):20-8. PubMed ID: 15253069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
    Harel Z; Biro FM; Kollar LM; Rauh JL
    J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
    Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introducing more contraceptive methods in Jordan.
    Gallagher M
    AVSC News; 1998; 36(1):3, 8. PubMed ID: 12321883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicolegal issues surrounding Depo-Provera easily overcome.
    Contracept Technol Update; 1992 Jan; 13(1):16, 18. PubMed ID: 12343460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depo-Provera: costs eat up clinic contraceptive budgets.
    Contracept Technol Update; 1999 Jan; 20(1):1-3. PubMed ID: 12349019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not FDA-approved, but experts recommend Depo-Provera.
    Contracept Technol Update; 1992 Jan; 13(1):1-7. PubMed ID: 12343458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women.
    Aktun H; Moroy P; Cakmak P; Yalcin HR; Mollamahmutoglu L; Danisman N
    Contraception; 2005 Jul; 72(1):24-7. PubMed ID: 15964288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depo-Provera highly effective as injectable contraceptive.
    Denniston GC
    Contracept Technol Update; 1985 Dec; 6(12):167-8. PubMed ID: 12280301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment counseling keeps patients on Depo.
    Contracept Technol Update; 1997 Oct; 18(10):125-6. PubMed ID: 12321212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depo-Provera use in Sri Lanka: acceptor characteristics, continuation and side effects.
    Basnayake S; Thapa S
    Adv Contracept Deliv Syst; 1986 Oct; 2(4):307-21. PubMed ID: 12341188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.